NL-004

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameNL-004
Drug Alias Namerecombinant human thymosin alpha-1 (Beijing Northland Biotech)NL-004
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionThymosin alpha-1 ligand
TargetsThymosin alpha-1
Therapy Area/IndicationsImmunologic Deficiency SyndromesNeoplasmsHepatitis C +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesBeijing Northland Biotech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBeijing Northland Biotech Co Ltd
Active IndicationsN/A
Inactive IndicationsImmunologic Deficiency SyndromesNeoplasmsHepatitis C +[4] 

Other Information

ATC CodeN/A
Related LinksN/A